Prothera Biologics, Inc.
Biotechnology company · Providence, Rhode Island, United States
Prothera Biologics, Inc. is a biotechnology company headquartered in Providence, Rhode Island, United States. It has received 17 US government small-business research awards (SBIR/STTR) from health agencies, $17 million in total, most recently in 2024. It has reported private securities offerings to the US SEC, most recently $750,000 sold in a notice filed in 2019.
Prothera Biologics at a glance
What does Prothera Biologics do?
US government research funding
17 SBIR/STTR small-business research awards from US health agencies, $16.8 million in total (2002 to 2024). NIH funding came from the National Institute of Allergy and Infectious Diseases, National Institute of Neurological Disorders and Stroke, National Institute of Child Health and Human Development.
Private fundraising reported to the SEC
3 Form D notices; the most recent reported $750,000 sold (2019).
Frequently asked questions about Prothera Biologics
Where is Prothera Biologics headquartered?
Prothera Biologics, Inc. is headquartered in Providence, Rhode Island, United States.
What does Prothera Biologics do?
Prothera Biologics, Inc. is a biotechnology company.
Similar companies
- Plans4Care INCProvidence, Rhode Island, United States
- Vitae Industries, IncProvidence, Rhode Island, United States
- Epivax, Inc.Providence, Rhode Island, United States
- Bolden Therapeutics, Inc.Providence, Rhode Island, United States
- Sention, Inc.Providence, Rhode Island, United States
- Lucidicor Inc.Providence, Rhode Island, United States
- Recursion PharmaceuticalsSalt Lake City, Utah, United States
- Vericel CorpBurlington, Massachusetts, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-25. Data licences